Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation

Bisphosphonates are the most widely prescribed treatment for postmenopausal osteoporosis, secondary osteoporosis, and male osteoporosis. Notwithstanding their high effectiveness and favorable safety profile, the adherence to bisphosphonate treatment remains low. Different treatment strategies aim to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinov, Plamen, Boyanov, Mihail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333827/
https://www.ncbi.nlm.nih.gov/pubmed/22532780
http://dx.doi.org/10.2147/IJWH.S18209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333827/
https://www.ncbi.nlm.nih.gov/pubmed/22532780
http://dx.doi.org/10.2147/IJWH.S18209

Ejemplares similares